.png){kind=icon}
-
Research
Research ModelsAnalysis Services
Bioanalytical Services Drug Metabolism and Pharmacokinetics (DMPK) StudiesLead Optimization
Lead Optimization Non-GLP Toxicology In Vivo Pharmacology Nonclinical Imaging Nonclinical Pathology Services PK/TK Analysis and Reporting Immunology Services Flow Cytometry RadiationProduct Testing
Crop Protection Chemical -
Manufacturing Support
Biopharm CMC SolutionsToxicology: Safety Assessment and Testing
General Toxicology Studies Genetic Toxicology Immunotoxicology Nonclinical Pathology Services Safety Pharmacology Services Developmental and Reproductive Toxicology (DART) Studies SEND 3.1Biomarkers
Biomarker Solution Center Translational Biomarkers -
Informatics
Xcellerate® Trial Design Xcellerate® Monitoring Xcellerate® Insights GlobalCODE® Specimen TrackingConsulting & Partnering
Alliance Management Early Phase Development Solutions Covance MarketPlace Drug Development Consulting Access & Strategy Evidence GenerationClinical Development
Clinical Pharmacology Early Clinical / Phase IIa Phase IIb / III Services Clinical Data Management Analysis and Reporting Regulatory Services Phase IV Clinical Research Unit Virtual Tours Clinical-Biotech Decentralized Clinical Trials -
Functional Service Provider (FSP)
FSP Education CenterClinical Testing
Flow Cytometry Solutions Central Laboratory Services Biomarker Solutions Biomarker Solution Center Translational Biomarker Solutions Companion Diagnostics Genomics Solutions Expanded Lab Management Solutions Vaccines & Novel Immunotherapeutics Personalized Study Performance ManagementCommercialization
Covance Market Access Patient Support Field Services Phase IV Solutions Patient Safety and Pharmacovigilance Services
-
Call Us
The Americas
+1.888.COVANCE (+1.888.268.2623)1.609.452.4440Europe/Africa
+00.800.2682.2682+44.1423.500888Asia/Pacific
+800.6568.3000+65.6.5686588Global Office Locations
-
Media Relations
Request an InterviewRequest a SpeakerInvestigators
Kit OrderingInvestors
Investor RelationsJob Seekers
Covance Careers
Preclinical
A549-LUC-C8
| Parameter | Information |
|---|---|
| Implant Type | Cells |
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
Histotype: Lung [NSCLC]
Tumor Line: Human
Copyright © 2020 Covance Inc. All rights reserved.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.